ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 256 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q4 2020. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,255,006 | -25.1% | 119,355 | -3.1% | 0.08% | -20.2% |
Q2 2023 | $5,683,031 | +12.1% | 123,196 | -2.5% | 0.10% | -4.8% |
Q1 2023 | $5,068,520 | -14.8% | 126,397 | -1.6% | 0.10% | -20.0% |
Q4 2022 | $5,950,440 | +10.2% | 128,436 | -1.5% | 0.13% | +4.8% |
Q3 2022 | $5,401,000 | -32.5% | 130,418 | -2.7% | 0.12% | -28.7% |
Q2 2022 | $7,998,000 | -19.2% | 134,058 | -1.6% | 0.17% | -0.6% |
Q1 2022 | $9,897,000 | -16.9% | 136,279 | -3.7% | 0.18% | -14.6% |
Q4 2021 | $11,905,000 | -7.3% | 141,574 | -0.5% | 0.20% | -13.5% |
Q3 2021 | $12,839,000 | -8.1% | 142,356 | -2.8% | 0.24% | -6.3% |
Q2 2021 | $13,970,000 | -15.6% | 146,515 | +0.8% | 0.25% | -19.7% |
Q1 2021 | $16,543,000 | -24.5% | 145,290 | -8.3% | 0.32% | -29.2% |
Q4 2020 | $21,921,000 | +59.1% | 158,355 | -5.6% | 0.44% | +36.1% |
Q3 2020 | $13,782,000 | +1.1% | 167,686 | -3.7% | 0.33% | -2.7% |
Q2 2020 | $13,626,000 | +71.5% | 174,199 | -2.6% | 0.34% | +39.4% |
Q1 2020 | $7,943,000 | -12.4% | 178,771 | -15.8% | 0.24% | +21.1% |
Q4 2019 | $9,071,000 | +190.5% | 212,387 | +190.9% | 0.20% | +168.9% |
Q3 2019 | $3,123,000 | – | 73,007 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 727,426 | $25,932,737 | 4.72% |
RTW INVESTMENTS, LP | 5,405,089 | $192,691,423 | 4.07% |
First Light Asset Management, LLC | 1,125,032 | $40,107,391 | 3.81% |
CHI Advisors LLC | 215,000 | $7,664,750 | 3.04% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 250,052 | $8,914,354 | 3.00% |
SPHERA FUNDS MANAGEMENT LTD. | 259,135 | $9,238,163 | 1.68% |
Rock Springs Capital Management LP | 1,476,441 | $52,635,122 | 1.41% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 679,459 | $24,222,713 | 1.31% |
Privium Fund Management B.V. | 115,241 | $4,108,341 | 1.22% |
SECTOR GAMMA AS | 115,166 | $4,105,668 | 1.05% |